Fact-checked by Grok 2 weeks ago

Irregular menstruation

Irregular menstruation, also referred to as (AUB), encompasses any deviation from the typical pattern in reproductive-aged individuals, including variations in the frequency, regularity, duration, or volume of outside of . A normal generally occurs every 21 to 35 days, with bleeding lasting 2 to 7 days and involving a blood loss of 5 to 80 milliliters per cycle. In contrast, irregular menstruation may manifest as cycles shorter than 21 days (), longer than 35 days (oligomenorrhea), prolonged bleeding exceeding 7 days, excessively heavy flow (menorrhagia), absent periods (amenorrhea), or spotting between cycles. This condition affects 14% to 25% of menstruating individuals, with higher prevalence during (menarche) and the perimenopausal transition, where up to one-third may experience episodes. Irregularities can be classified using the PALM-COEIN system, which distinguishes structural causes—such as uterine polyps, , leiomyomas (fibroids), or malignancy—from nonstructural factors like coagulopathies, ovulatory dysfunction, endometrial issues, iatrogenic effects, or other unclassified etiologies. Common underlying causes include hormonal imbalances (e.g., from or disorders), extreme weight changes, excessive exercise, eating disorders, uterine fibroids or polyps, , and certain medications. While occasional irregularities may resolve without intervention, persistent or severe cases warrant medical evaluation to rule out serious conditions like or cancer, particularly in those over age 45 or with risk factors. typically involves a detailed menstrual history, , laboratory tests (e.g., , ), and imaging such as transvaginal , with endometrial recommended for persistent bleeding. Treatment options range from hormonal therapies (e.g., oral contraceptives) and nonsteroidal anti-inflammatory drugs to procedural interventions like or , tailored to the underlying cause and individual needs.

Overview

Definition

Irregular menstruation, also known as , refers to any deviation from the typical pattern, characterized by variations in cycle length, duration of , or volume of flow that differ from the established norm of cycles lasting 21 to 35 days and episodes spanning 2 to 7 days. This encompasses unpredictable timing of periods, such as cycles shorter than 21 days () or longer than 35 days (oligomenorrhea), as well as alterations in characteristics like prolonged menses or excessive heaviness. These irregularities can manifest as missed periods, spotting between cycles, or inconsistent flow, impacting reproductive and . A common underlying mechanism for irregular menstruation is , the absence of during a , which disrupts the hormonal balance necessary for regular cyclic bleeding. often leads to irregular patterns, including skipped cycles where no bleeding occurs or irregular spotting due to unopposed effects on the uterine lining. While not all irregular cycles stem from , it represents a key physiological deviation from the ovulatory phases. The understanding and definition of irregular menstruation have evolved significantly since the early , driven by advances in endocrine research that illuminated the role of hormones in menstrual . Prior to these developments, was inconsistent and descriptive; by , concepts like dysfunctional uterine bleeding emerged, linking irregularities to endocrine dysfunction without precise . Modern definitions, refined through international consensus such as the FIGO systems in the , now provide structured criteria emphasizing measurable parameters informed by hormonal insights.

Normal versus irregular cycles

The normal menstrual cycle typically averages 28 days in length, ranging from 21 to 35 days, and consists of four distinct phases: the (days 1-13), ovulatory phase (around day 14), (days 15-28), and menstrual phase (days 1-5, involving shedding of the uterine lining). During , average blood loss is 30-40 mL per cycle, with volumes exceeding 80 mL considered excessive. This cycle is regulated by fluctuating levels of and progesterone, which prepare the body for potential . Signs of a regular include consistent lengths between periods, with minimal variation of less than 7 days from one cycle to the next, predictable typically occurring around day 14 in a 28-day cycle, and the absence of between periods. Menstrual in regular cycles lasts 2-7 days and is moderate in flow without significant spotting. Irregular cycles deviate from these norms, such as those shorter than 21 days () or longer than 35 days (oligomenorrhea), or those with cycle-to-cycle variations exceeding 7-9 days. For instance, a might experience cycles of 25 days one month and 40 days the next, indicating irregularity. Cycle patterns vary by age and life stage; in , particularly the first few years after , cycles are often longer and more variable, with averages ranging from 32 to 61 days in the initial gynecological year due to immature hypothalamic-pituitary-ovarian axis function. Similarly, during perimenopause, cycles become irregular with persistent variations of 7 or more days, often lengthening as ovarian function declines.

Causes

Hormonal factors

Irregular menstruation often stems from disruptions in the hypothalamic-pituitary-ovarian (HPO) axis, which orchestrates the through interactions among key reproductive hormones. Follicle-stimulating hormone (FSH) and (LH), secreted by the , stimulate development and , respectively. , produced by growing follicles, promotes endometrial proliferation during the , while progesterone, secreted by the post-, stabilizes the in the . Imbalances, such as insufficient progesterone due to , can lead to unopposed exposure, resulting in irregular or heavy . Specific endocrine conditions exemplify these disruptions. In (PCOS), elevated androgens and an increased LH-to-FSH ratio impair , causing oligomenorrhea or amenorrhea in up to 70-80% of affected women, who represent 5-10% of reproductive-age individuals. Hypothalamic amenorrhea arises from suppressed (GnRH) pulsatility, reducing FSH and LH secretion and halting , often linked to energy deficits or stress. Thyroid disorders also contribute: elevates , which stimulates and disrupts GnRH, leading to oligomenorrhea or heavy menses; , conversely, shortens cycles or causes light, irregular bleeding. Physiological transitions further highlight hormonal influences. During , the immature HPO axis results in inconsistent GnRH pulses, leading to anovulatory cycles and irregular menstruation in 50-80% of adolescents for the first few years post-menarche. In perimenopause, declining reduces and progesterone production, causing cycle lengthening or skipping as follicle responsiveness wanes. Hormonal causes, primarily endocrine in nature, account for a significant portion of irregular cycles, with overall of such irregularities ranging from 14% to 25% among reproductive-age women.

Lifestyle and medical conditions

Lifestyle factors can significantly disrupt menstrual regularity by influencing energy balance, hormonal signaling, and overall physiological stress. or gain alters levels, a hormone produced by fat cells that signals the brain to regulate reproductive function; rapid changes in body weight create a U-shaped association with menstrual irregularity, where both and increase risk through disrupted appetite and . Excessively low body weight, often about 10% under normal for age and height, suppresses and leads to amenorrhea, commonly seen in eating disorders like . Conversely, elevates production from , prolonging cycles and contributing to irregular bleeding patterns. Excessive exercise, particularly in athletes, suppresses (GnRH) pulsatility due to high energy expenditure and reduced body fat, interrupting the hypothalamic-pituitary-ovarian axis and causing oligomenorrhea or amenorrhea. This effect is compounded by the physical and psychological demands of rigorous training, such as in or endurance sports, where low energy availability halts menstrual cycles to conserve resources. further exacerbates these disruptions by elevating , which interferes with GnRH release and can lead to hypothalamic amenorrhea; mental or emotional alters hypothalamic function, temporarily stopping until stress levels decrease. Poor nutrition, including deficits or deficiencies in key nutrients like iron, contributes to menstrual irregularities by impairing availability and hormonal balance, often overlapping with low body weight and excessive exercise. Sustained low caloric intake signals the body to reduce reproductive function, mimicking states and leading to delayed or absent periods. Epidemiological data indicate that lifestyle factors like these are implicated in 20-25% of irregular menstruation cases among athletes and individuals with eating disorders, with one study of high school female athletes reporting 23.5% prevalence of menstrual irregularity, including 17.1% oligomenorrhea and 5.3% secondary amenorrhea. Medical conditions unrelated to primary endocrine disorders can also trigger irregular menstruation through structural, inflammatory, or systemic mechanisms. Coagulopathies, such as , impair blood clotting and cause heavy or prolonged bleeding, affecting up to 20% of adolescents with menorrhagia. Uterine fibroids, benign tumors in the uterine wall, cause heavy or prolonged menstrual bleeding by increasing the endometrial surface area and disrupting normal shedding; submucosal fibroids particularly lead to irregular spotting between periods due to their location within the . Similarly, endometrial polyps, growths on the uterine lining, result in abnormal bleeding patterns, including intermenstrual spotting or heavy flow, by interfering with the uniformity of the endometrial layer. (PID), an infection of the upper reproductive tract often caused by sexually transmitted bacteria like or , inflames the uterus and fallopian tubes, leading to unusual between periods or after . Endometriosis, where tissue resembling the uterine lining grows outside the , causes painful and irregular periods through and scarring; the ectopic tissue responds to hormonal cycles by thickening and bleeding, resulting in heavy menstrual flow lasting over seven days and extending beyond typical . Chronic illnesses such as contribute via associated , which can manifest as irregular cycles, particularly when linked to conditions affecting ovarian function. Celiac disease, an autoimmune disorder causing intestinal , indirectly disrupts through nutrient deficiencies like iron and vitamins, leading to reproductive issues including irregular bleeding. Iatrogenic causes arise from medical interventions or substance use that alter hormonal or uterine . Certain medications, such as hormonal contraceptives, induce irregular or spotting, especially in the initial months, due to fluctuations in and progestin levels that thin the endometrial lining unevenly. Antipsychotics, particularly those elevating like , cause menstrual irregularities through hyperprolactinemia, which suppresses and leads to amenorrhea or oligomenorrhea in up to a significant portion of premenopausal women. Post-surgical effects, such as after , permanently alter ; a total removes the , halting periods entirely, while partial procedures may leave residual from the cervical stump. Substance use further contributes to disruptions in menstrual regularity. Smoking accelerates estrogen metabolism in the liver, shortening cycles and increasing irregularity risk as a modifiable environmental factor. Excessive alcohol consumption affects reproductive hormones, potentially lengthening cycles or inducing anovulation through interference with gonadotropin secretion.

Types

Cycle length variations

Cycle length variations encompass deviations in the interval between menstrual periods, typically defined as normal ranging from 21 to 35 days, with disruptions classified into specific subtypes based on frequency and timing. These irregularities often stem from disruptions in or hormonal regulation, though detailed causes are addressed elsewhere. Oligomenorrhea is characterized by prolonged menstrual cycles exceeding 35 days in length. This condition frequently results from infrequent , leading to symptoms such as light bleeding or entirely absent periods in affected cycles. Amenorrhea represents the complete absence of menstrual bleeding. Primary amenorrhea is identified when menstruation has not begun by age 15 years, or within three years of the onset of secondary such as . Secondary amenorrhea involves the cessation of previously established menses for at least three months in individuals with regular cycles or six months in those with prior irregularity. Subtypes include physiologic forms, such as those occurring during or , and pathologic variants arising from underlying disorders. Polymenorrhea features excessively frequent menstrual cycles, with intervals shorter than 21 days. It often signals a shortened , characterized by inadequate progesterone secretion following , which may elevate the risk of through unopposed exposure. Amenorrhea affects approximately 3-5% and oligomenorrhea 10-20% of women of reproductive age, with prevalence rising to 20-30% among adolescents due to maturing hypothalamic-pituitary-ovarian axis dynamics. These length-based irregularities may briefly relate to hormonal imbalances like , but such etiologies are explored in dedicated sections on causes.

Bleeding pattern irregularities

Bleeding pattern irregularities refer to variations in the volume, duration, consistency, or timing of menstrual flow itself, distinct from alterations in cycle intervals. These disruptions can manifest as excessive blood loss, unexpected spotting, or prolonged bleeding, often impacting daily activities and . Such patterns are common among reproductive-aged women and may signal underlying physiological or pathological processes. Menorrhagia, also known as , is characterized by excessive or prolonged menstrual flow, typically defined as blood loss exceeding 80 mL per cycle or lasting more than seven days. This condition increases the risk of due to significant blood loss over time. Women experiencing menorrhagia may require frequent pad or changes, often every hour, and can pass large blood clots. Hypomenorrhea involves diminished menstrual flow, generally quantified as less than 5 mL of per cycle, and stands apart from patterns of excessive . While primarily a descriptor of volume, it can accompany other disruptions and warrants evaluation to rule out associated hormonal factors. Metrorrhagia involves irregular or spotting between menstrual periods, sometimes referred to as intermenstrual or breakthrough . This pattern disrupts the expected cyclical flow and can occur unpredictably, often in small amounts but persistently enough to cause concern. Menometrorrhagia refers to prolonged and irregular heavy , combining features of menorrhagia and metrorrhagia. , occurring after , serves as a for potential or vaginal irregularities, warranting prompt evaluation. Associated symptoms of these bleeding irregularities often include the passage of blood clots larger than a quarter and or from chronic blood loss leading to . affects an estimated 10-30% of women globally during their reproductive years.

Diagnosis

Clinical evaluation

The clinical evaluation of irregular menstruation begins with a detailed to identify patterns, potential causes, and associated symptoms. Clinicians inquire about cycle tracking methods, such as the use of calendars or mobile applications, to document the frequency, duration, and variability of menstrual cycles; adolescent cycles range from 21 to days, with evaluation recommended if intervals exceed 90 days. The age of and onset of irregularities are assessed, as primary amenorrhea is defined as no menses by age 15 or within three years of , while irregularities in reproductive-aged women may signal ovulatory dysfunction. Family history is explored for endocrine disorders, such as (PCOS) or premature ovarian failure, and disorders that could contribute to abnormal patterns. Questions also cover sexual activity to rule out as a cause of , along with symptoms like unintentional weight changes, which may indicate hypothalamic amenorrhea from undernutrition or excessive exercise, or suggesting androgen excess. A comprehensive follows to detect structural or systemic clues. The evaluates for anatomical anomalies, such as uterine fibroids or polyps, by inspecting the external genitalia and performing a speculum and bimanual assessment if indicated, particularly in adolescents after . (BMI) is calculated to identify obesity or underweight states that influence hormonal balance and cycle regularity. Signs of excess, including , , or alopecia, are examined, as these may point to conditions like PCOS affecting up to 10% of reproductive-aged women. Certain features in the history and exam raise red flags requiring urgent referral. Sudden onset of irregular bleeding, especially with severe , may indicate acute issues like or and necessitates immediate evaluation. Postmenopausal bleeding, defined as any bleeding after 12 months of amenorrhea, warrants prompt investigation to exclude or malignancy. According to American College of Obstetricians and Gynecologists (ACOG) guidelines, evaluation of menstrual cycles should begin at age 13 during preventive health visits, treating the cycle as a vital sign to detect irregularities early and guide further assessment, potentially including hormonal testing if clinical findings suggest endocrine involvement.

Laboratory and imaging tests

Laboratory and imaging tests serve as objective tools to identify underlying causes of irregular menstruation, such as hormonal imbalances, structural abnormalities, or systemic conditions, following initial clinical assessment. These tests are selected based on patient history and examination findings to confirm diagnoses like (PCOS), (POI), or hyperprolactinemia. Blood tests form the cornerstone of laboratory evaluation, beginning with a pregnancy test using serum (hCG) to rule out as the primary cause of amenorrhea or irregular bleeding in reproductive-aged individuals. A comprehensive hormone panel typically includes (FSH), (LH), , progesterone, , and (TSH) to assess ovulatory function and endocrine disorders. For instance, elevated FSH levels (>25 /L on one occasion) suggest POI per 2024 ASRM guidelines, while low FSH and LH with below 30 pg/mL indicate . (AMH) levels may also be measured to assess in cases of suspected POI. levels above 20 ng/mL prompt further investigation for hyperprolactinemia, and abnormal TSH requires free thyroxine follow-up to detect dysfunction. In cases of suspected , such as in PCOS, total testosterone and (DHEAS) are measured. Imaging studies provide visualization of reproductive structures to detect anomalies contributing to irregular cycles. Pelvic ultrasound, often transvaginal, is the first-line imaging modality to evaluate for ovarian cysts, fibroids, or polycystic ovarian morphology meeting criteria for PCOS. It also assesses endometrial thickness to evaluate for potential , though decisions for are guided by clinical risk factors such as age over 45 or persistent anovulatory bleeding, rather than thickness alone. For suspected pituitary issues, such as in persistent hyperprolactinemia, (MRI) of the is recommended to identify adenomas or other lesions. Advanced tests are employed when initial evaluations suggest specific etiologies. Endometrial is indicated in anovulatory irregular to assess for , particularly in women over 45 years or those with unopposed exposure, involving sampling of the uterine lining for histopathological analysis. In suspected PCOS, an oral evaluates , with impaired glucose tolerance supporting the diagnosis alongside clinical and findings. Recent guidelines emphasize cost-effective sequencing, starting with targeted labs before , to optimize diagnostic yield while minimizing unnecessary procedures.

Management and treatment

Non-medical approaches

Lifestyle modifications play a key role in managing mild cases of irregular menstruation by addressing factors that influence hormonal balance. Maintaining a healthy (BMI) within the normal range of 18.5 to 24.9 kg/m² is associated with improved menstrual regularity, as both and conditions can disrupt cycle length and . For instance, women with (BMI ≥30 kg/m²) are twice as likely to experience irregular cycles compared to those with normal weight, while status (BMI <18.5 kg/m²) often leads to amenorrhea or oligomenorrhea due to reduced energy availability. A balanced rich in and supports menstrual health; , common in women with heavy or irregular bleeding, can exacerbate cycle disruptions, and supplementation or dietary intake from sources like leafy greens and lean meats has been shown to mitigate these effects. Similarly, correlates with menstrual disorders, including irregular cycles, and adequate levels from fortified foods or sunlight exposure may help regulate and hormonal function. Moderate exercise, such as 150 minutes per week of aerobic activity like brisk walking or , promotes cycle regularity by improving insulin sensitivity and reducing inflammation, particularly in conditions like (PCOS) where irregularity is prevalent. Stress reduction techniques offer non-invasive ways to normalize cycles influenced by psychological factors, which affect up to 30% of menstrual irregularities through hypothalamic-pituitary-ovarian axis disruption. Mindfulness-based practices, such as meditation or mindfulness-based stress reduction (MBSR), have demonstrated benefits in restoring cycle regularity in stress-related cases; for example, mind-body interventions improved menstrual outcomes in women with PCOS, a common cause of irregularity, by lowering cortisol levels and enhancing quality of life. Yoga, including poses and breathing exercises, reduces premenstrual symptoms and supports cycle normalization, with randomized trials showing alleviation of depressive and physical symptoms that indirectly stabilize menstrual patterns. Cognitive behavioral therapy (CBT) addresses stress-induced amenorrhea effectively; studies indicate that over 70% of women with stress- or exercise-related absent periods recover menstrual function following CBT combined with lifestyle adjustments. These approaches, when practiced consistently for 8-12 weeks, yield measurable improvements in cycle predictability without pharmacological intervention. Cycle tracking empowers individuals to monitor and predict menstrual patterns, aiding in the management of irregularities through increased awareness of fertile windows and symptom triggers. Mobile applications, such as those using algorithms based on user-input data like cycle start dates and symptoms, provide predictions for ovulation and period onset, helping users identify deviations early. Basal body temperature (BBT) tracking, where daily morning temperatures are recorded to detect the post-ovulatory rise (typically 0.5-1°F), offers a reliable, low-cost method for confirming ovulation in irregular cycles and supporting fertility awareness. Wearable devices integrating BBT with heart rate variability further enhance accuracy, allowing for personalized insights that can guide lifestyle adjustments to foster regularity. Regular use of these tools has been associated with better self-management of mild irregularities, though they should complement, not replace, professional evaluation. Natural remedies, such as herbal supplements, are sometimes explored for progesterone support in irregular menstruation, but evidence remains limited and requires caution due to variable efficacy and potential interactions. (chasteberry), traditionally used for cycle regulation, shows promise in addressing hyperprolactinemia-related irregularities; clinical studies report improvements in menstrual frequency (up to 79%) and reduced pain in women with cycle disorders after 3-6 months of use at standardized doses (20-40 mg/day of extract). However, systematic reviews highlight inconsistent results for broader menstrual irregularities, with benefits more established for than for cycle length variations, and long-term safety data are sparse. Consultation with a healthcare provider is essential before initiating such remedies to avoid adverse effects like or hormonal imbalances.

Pharmacological and procedural interventions

Hormonal therapies form the foundation of pharmacological management for irregular menstruation, targeting ovulatory dysfunction and endometrial instability. Combined oral contraceptives (COCs), containing and progestin, regulate cycle length by inhibiting and promoting consistent endometrial shedding, effectively normalizing irregular patterns in conditions such as or (PCOS). Clinical consensus supports their use for menstrual suppression and cycle stabilization, with extended regimens minimizing breakthrough bleeding. Progestin-only challenges, typically involving (10 mg daily for 5-10 days), induce withdrawal bleeding to evaluate status and restore cycling in hypoestrogenic or anovulatory states, confirming responsiveness in up to 80% of cases without structural pathology. This approach aids in differentiating causes and initiating therapy for oligomenorrhea or amenorrhea. Non-hormonal options include and nonsteroidal anti-inflammatory drugs (NSAIDs), which reduce blood loss by 30-50% in . Condition-specific pharmacological interventions address underlying etiologies to restore menstrual regularity. In PCOS, metformin targets , enhancing ovulatory and improving menstrual regularity (e.g., more cycles per 6 months), as shown in meta-analyses of randomized trials (very low certainty evidence). For hypothyroidism-induced irregularities, replacement normalizes levels, thereby reinstating ovulatory cycles and potentially improving menstrual patterns. In endometriosis, (GnRH) agonists like leuprolide acetate suppress pituitary gonadotropin secretion, inducing a hypoestrogenic state that halts menstruation and regresses lesions, alleviating associated and irregular bleeding in 70-90% of patients during 3-6 months of treatment. Procedural interventions provide targeted relief for acute heavy bleeding or cases refractory to medications. (D&C) involves and mechanical removal of the , offering immediate and diagnostic tissue sampling for unexplained menorrhagia. Guidelines endorse D&C for acute unresponsive to initial , though it is not a long-term solution. For persistent irregularities, techniques—such as radiofrequency or thermal balloon methods—destroy the endometrial lining, achieving significant reduction in bleeding (70-90% satisfaction) or amenorrhea (up to 50%) in women with benign . , entailing surgical removal of the , serves as a definitive option for refractory cases where preservation is not desired, eliminating entirely but reserved due to its invasiveness. Recent advancements in (LARCs), notably the levonorgestrel-releasing intrauterine system (LNG-IUS), have enhanced options for cycle regulation. Inserted intrauterinely, the LNG-IUS delivers localized progestin to thin the , reducing bleeding volume by 82% overall and promoting predictable light or absent menses in 70-95% of users with , per 2023-2024 clinical data. These devices offer sustained efficacy for up to 5-8 years, outperforming oral therapies in quality-of-life improvements for heavy or irregular patterns.

Complications

Reproductive health impacts

Irregular menstruation often stems from ovulatory disorders, such as , which disrupts the release of eggs necessary for and leads to subfertility in affected individuals. Chronic accounts for approximately 25% to 30% of cases and is frequently manifested as irregular menstrual cycles, including oligomenorrhea or amenorrhea. (PCOS), a leading endocrine disorder, contributes significantly to this association, as it underlies up to 70% of anovulation cases and commonly presents with irregular periods that impair and . Women with PCOS face a substantially elevated risk due to these hormonal disruptions, with studies estimating that ovulatory dysfunction from PCOS affects in 70% to 80% of untreated cases. Population-level data underscore the scale of this impact, with irregular menstrual cycles linked to heightened risk compared to regular cycles, primarily arising from inconsistent , making natural challenging without intervention. Beyond , irregular menstruation elevates risks once occurs, particularly in untreated cases of oligoamenorrhea. Women with these patterns experience higher rates of due to endometrial irregularities and hormonal imbalances that compromise implantation and early fetal development. Additionally, a history of irregular cycles signals underlying hormonal disruptions that independently predict mellitus, increasing its risk by up to 2.5-fold through mechanisms like . For individuals facing premature ovarian insufficiency (POI)—a condition often heralded by progressive irregular menstruation—fertility preservation strategies are crucial to mitigate reproductive loss. Egg freezing, or , offers a viable option for those at risk or in early stages of POI, allowing retrieval and storage of viable eggs before ovarian function declines further, thereby preserving future conception possibilities via assisted reproductive technologies. Guidelines from societies emphasize counseling on such preservation for women with POI risk factors, as spontaneous ceases in most cases, rendering natural improbable without prior intervention.

Systemic health risks

Untreated irregular menstruation can lead to significant metabolic disturbances, particularly through commonly observed in (PCOS), a frequent cause of cycle irregularities. This promotes and impaired glucose tolerance, elevating the risk of by 5- to 10-fold compared to women without PCOS. Additionally, these metabolic changes contribute to , visceral , and , collectively heightening cardiovascular risks such as coronary heart disease and nonfatal . Hypoestrogenism associated with amenorrhea, an extreme manifestation of irregular menstruation, impairs bone health by accelerating resorption and reducing formation, thereby increasing risk. Women experiencing , for instance, exhibit annual bone mineral density (BMD) losses of 2.4% at the and 2.6% at the , reflecting estrogen's critical role in maintaining skeletal integrity. This progressive BMD decline, if prolonged, can result in irreversible fragility fractures and reduced quality of life in later years. Chronic underlying many cases of irregular menstruation results in unopposed exposure, which stimulates endometrial and elevates cancer risk. This mechanism drives a 2- to 3-fold higher incidence of in affected women, as the absence of progesterone fails to counter 's mitogenic effects, often leading to as a precursor . Screening guidelines from authoritative bodies recommend endometrial or transvaginal ultrasonography for women with persistent anovulatory , especially those over 45, obese, or with PCOS, to detect early or . Irregular menstruation correlates with elevated burdens, including anxiety and , through disruptions in estrogen-mediated neuroendocrine . Recent cohort studies indicate that 20-30% of women with menstrual irregularities experience clinically significant disorders, often bidirectional with underlying stress or hypothalamic dysfunction exacerbating cycle variability. These associations underscore the need for integrated psychological screening in affected individuals to mitigate long-term emotional impacts.

References

  1. [1]
    Abnormal Uterine Bleeding - StatPearls - NCBI Bookshelf - NIH
    Feb 21, 2025 · Abnormal uterine bleeding (AUB) is a broad term that describes irregularities in the menstrual cycle involving the parameters of frequency, ...Abnormal Uterine Bleeding · Evaluation · Treatment / Management
  2. [2]
    What are menstrual irregularities? | NICHD
    Jan 31, 2017 · 1. However, 14% to 25% of women have irregular menstrual cycles, meaning the cycles are shorter or longer than normal; are heavier or lighter ...
  3. [3]
    Menstrual cycle: What's normal, what's not - Mayo Clinic
    Apr 22, 2023 · What causes menstrual cycle irregularities? · Pregnancy or breast-feeding. A missed period can be an early symptom of pregnancy. · Eating ...
  4. [4]
    Heavy and Abnormal Periods | ACOG
    What causes abnormal periods? Some causes of abnormal periods may include: Polycystic ovary syndrome (PCOS). Bleeding disorders. Eating disorders or extreme ...
  5. [5]
    The Impact of Irregular Menstruation on Health: A Review of ... - PMC
    Nov 20, 2023 · Irregular periods can occur due to changes in the levels of the hormones progesterone and estrogen, which affect the normal pattern of the cycle ...
  6. [6]
    Anovulatory Bleeding - StatPearls - NCBI Bookshelf
    Mar 23, 2025 · Anovulatory bleeding is a type of abnormal uterine bleeding (AUB) that occurs when ovulation fails to occur during the menstrual cycle.
  7. [7]
    Adolescent Anovulation: Maturational Mechanisms and Implications
    Normal adolescent anovulation causes only minor menstrual cycle irregularity: most cycles range from 21–45 days, even in the first postmenarcheal year, 90% by ...
  8. [8]
    Historical Perspectives and Evolution of Menstrual Terminology - PMC
    Feb 28, 2022 · In this article, we explore the history and evolution of menstrual terminology and discuss the two International Federation of Gynecology and Obstetrics (FIGO) ...
  9. [9]
    Physiology, Menstrual Cycle - StatPearls - NCBI Bookshelf
    Sep 27, 2024 · For research purposes, light menstrual bleeding is typically defined as less than 5 mL of blood loss per cycle. Several factors can influence ...
  10. [10]
    The Normal Menstrual Cycle and the Control of Ovulation - NCBI - NIH
    Aug 5, 2018 · As mentioned earlier, the average amount of menstrual blood loss is 30 mL and greater than 80 mL is considered abnormal [4].ABSTRACT · THE FOLLICULAR PHASE... · LUTEAL PHASE · MENSTRUATION
  11. [11]
    Menstrual cycle length variation by demographic characteristics from ...
    May 29, 2023 · One study in adolescents reported African-American girls had moderately shorter cycle length compared to European-American girls. Two studies ...Missing: perimenopause | Show results with:perimenopause
  12. [12]
    Menstruation in Girls and Adolescents: Using the Menstrual Cycle as ...
    Menstrual cycles are often irregular during adolescence, particularly the interval from the first cycle to the second cycle. Most females bleed for 2–7 days ...Menarche · Cycle Length And Ovulation · Abnormal Uterine Bleeding<|control11|><|separator|>
  13. [13]
    Analyzing the Atypical – Methods for studying the menstrual cycle in ...
    The mean cycle length in the first gynecological year ranges from 32 to 61 days with high variability (Gunn 2018). This contrasts with adult (>18 years) ...
  14. [14]
    Transitioning to the Menopausal Transition: A Scoping Review ... - NIH
    Entry into the early menopausal transition, stage −2, requires persistent variation in menstrual cycle length of 7 or more days in consecutive cycles. The ...Table 2 · Results · 2.6. Genes And Late...
  15. [15]
    The Menstrual Disturbances in Endocrine Disorders - NIH
    Oct 14, 2020 · In general, hypothyroidism causes different menstrual conditions such as irregular menses, heavy bleeding, oligomenorrhea, amenorrhea, ...
  16. [16]
    Endocrine Disorders and Menstrual Disturbances: A Review
    Nov 21, 2022 · This review article summarizes menstrual disturbances in endocrine diseases, such as PCOS, diabetes, hyperprolactinemia, hypothyroidism, thyrotoxicosis, and ...
  17. [17]
    Amenorrhea - Symptoms and causes - Mayo Clinic
    Feb 9, 2023 · Amenorrhea (uh-men-o-REE-uh) is the absence of menstruation, often defined as missing one or more menstrual periods.
  18. [18]
    Association between Body Weight Changes and Menstrual Irregularity
    We found a U-shaped pattern of association between body weight changes and menstrual irregularity among obese women in the general Korean population.Missing: poor | Show results with:poor
  19. [19]
    The effects of weight loss-related amenorrhea on women's health ...
    Jan 31, 2023 · As a combination of factors are often involved in its pathophysiology, including sustained low weight, excessive exercise, poor nutritional ...
  20. [20]
    Chronic Stress and Ovulatory Dysfunction: Implications in Times of ...
    May 23, 2022 · Despite regular menses generally being considered an indicator of ovulation, they can, in fact, be associated with anovulation (3). Therefore, ...
  21. [21]
    Prevalence of the Female Athlete Triad Syndrome Among High ...
    Results Among all athletes, 18.2%, 23.5%, and 21.8% met the criteria for disordered eating, menstrual irregularity, and low bone mass, respectively. Ten girls ( ...
  22. [22]
    Uterine fibroids - Symptoms and causes
    ### Summary: How Uterine Fibroids Cause Irregular Menstruation or Abnormal Bleeding
  23. [23]
    Pelvic inflammatory disease (PID)-Pelvic inflammatory disease (PID) - Symptoms & causes - Mayo Clinic
    ### Summary: How PID Causes Abnormal Uterine Bleeding or Irregular Periods
  24. [24]
    Endometriosis - Symptoms and causes
    ### Summary: How Endometriosis Causes Irregular or Painful Periods
  25. [25]
    Type 2 diabetes - Symptoms and causes
    ### Summary: Does Type 2 Diabetes Cause Irregular Periods?
  26. [26]
    Celiac disease - Symptoms and causes
    ### Summary: Does Celiac Disease Cause Irregular Menstruation?
  27. [27]
    Birth control: Your questions, answered
    ### Side Effects of Contraceptives on Menstrual Cycles
  28. [28]
    The Effects of Antipsychotics on Prolactin Levels and Women's ...
    Some studies support that a high percentage of menstrual irregularity and estrogen deficiency cannot be fully explained by antipsychotic induced prolactin ...
  29. [29]
    7 Things You Didn't Know About Hysterectomy - ACOG
    Your periods may end, but you may still ovulate and have cramps each month. After a supracervical (partial) hysterectomy, you may continue to have some monthly ...
  30. [30]
    Alcohol intake, reproductive hormones, and menstrual cycle function
    Background: Although habitual low-to-moderate alcohol intake has been linked with reduced all-cause mortality and morbidity, the effect of recent alcohol ...
  31. [31]
    Abnormal Uterine Bleeding
    ### Summary of Cycle Length Variations from ACOG FAQ on Abnormal Uterine Bleeding
  32. [32]
    Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian ...
    However, oligomenorrhea, defined as infrequent or irregular periods, is estimated to occur in 75-85% of women with PCOS and less than 18% of women without PCOS, ...
  33. [33]
    Amenorrhea - StatPearls - NCBI Bookshelf - NIH
    Feb 25, 2024 · Primary amenorrhea is defined as having no history of menstruation by the age of 15 years or 3 years after thelarche; secondary amenorrhea is ...Etiology · Epidemiology · History and Physical · Evaluation
  34. [34]
    Amenorrhea
    Primary amenorrhea occurs when a girl has not had her first period by age 16. Secondary amenorrhea describes women who experience an absence of more than three ...
  35. [35]
    Prevalence of menstrual problems and their association with ... - PMC
    Oligomenorrhea is a condition in which the menstrual cycle lasts longer than 35 days. Hypomenorrhea is a condition in which uterine bleeding may be slight in ...
  36. [36]
    The Association between Oligomenorrhea, Onset of Menopause ...
    Aug 31, 2018 · The prevalence of oligomenorrhea among the general population is 13.5%.2 The most common cause of anovulation is PCOS,1 which occurs in 7 ...<|control11|><|separator|>
  37. [37]
    Prevalence of oligomenorrhea among women of childbearing age in ...
    Operational definitions and data collection ... Women with oligomenorrhea have menstruation intervals of more than 35 days. Infertility is the failure to achieve ...
  38. [38]
    Overview: Heavy periods - InformedHealth.org - NCBI Bookshelf - NIH
    Feb 25, 2025 · Doctors consider a woman to have heavy periods if she regularly loses more than 80 milliliters (2.7 ounces) of blood during one menstrual period.Bookshelf · Causes · DiagnosisMissing: risk | Show results with:risk
  39. [39]
    Heavy menstrual bleeding - Symptoms and causes - Mayo Clinic
    Aug 30, 2023 · Uterine polyps can cause irregular menstrual bleeding, bleeding after menopause, very heavy menstrual flow or bleeding between periods.
  40. [40]
    Abnormal Vaginal Bleeding - Clinical Methods - NCBI Bookshelf - NIH
    Adenomatous endometrial hyperplasia and endometrial adenocarcinoma may cause postmenopausal bleeding. Functioning ovarian tumors may cause a variety of ...
  41. [41]
    Dysmenorrhea: Painful Periods - ACOG
    Primary dysmenorrhea is the cramping pain that comes before or during a period. This pain is caused by natural chemicals called prostaglandins that are made in ...
  42. [42]
    None
    Nothing is retrieved...<|separator|>
  43. [43]
    Painful menstrual periods: MedlinePlus Medical Encyclopedia
    Apr 16, 2024 · Secondary dysmenorrhea is menstrual pain that develops later in women who have had normal periods. It is often related to problems in the uterus ...
  44. [44]
    Postmenopausal Bleeding - StatPearls - NCBI Bookshelf - NIH
    Jan 22, 2025 · Bleeding after menopause has been established, termed postmenopausal bleeding, is considered abnormal and is the reason for approximately two-thirds of all ...
  45. [45]
    Recognizing Gynecological Cancer in Primary Care: Risk Factors ...
    Mar 7, 2018 · Symptoms and Signs​​ The classic red flag symptom of postmenopausal bleeding, unexplained vaginal bleeding more than 12 months after menopausal ...Ovarian Cancer · Endometrial Cancer · Cervical Cancer
  46. [46]
    Clotting Factor Deficiencies as an Underlying Cause of Abnormal ...
    Jun 5, 2023 · According to the bibliography, up to 10–35% of women report Heavy Menstrual Bleeding (HMB) at some point during their reproductive lives [1].<|separator|>
  47. [47]
    Evaluation of Amenorrhea, Anovulation, and Abnormal Bleeding
    Jan 15, 2018 · Chronic anovulation may be viewed as a steady state in which the monthly rhythms associated with ovulation are not functional. Although ...<|control11|><|separator|>
  48. [48]
    Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged ...
    The purpose of this document is to provide evidence-based management guidelines for the evaluation of the reproductive-aged patient with AUB. A secondary ...
  49. [49]
    Current evaluation of amenorrhea: a committee opinion - ASRM
    The prevalence of amenorrhea not because of pregnancy, lactation, or menopause is approximately 3%–4% (3, 4). Requirements for normal menstrual function include ...
  50. [50]
    Menstrual patterns and problems in association with body mass ...
    Sep 30, 2019 · Adolescent girls <18.5 kg/m2 were defined as underweight, who had BMI between 18.5 and 24.9 were considered as having normal BMI and who had >25 ...
  51. [51]
    The effects of obesity on the menstrual cycle - PMC - NIH
    Jul 21, 2022 · Specifically, women with obesity (BMI ≥30 kg/m2) were twice as likely as normal weight women to have an irregular menstrual cycle. Furthermore, ...
  52. [52]
    Minerals and the Menstrual Cycle: Impacts on Ovulation and ... - PMC
    As a consequence, an iron deficiency, often manifested as anemia, can lead to disturbances in menstrual cycles. Hormonal imbalances from such deficiencies can ...
  53. [53]
    The Relationship between Vitamin D Status and the Menstrual Cycle ...
    Nov 11, 2018 · The study demonstrates a relationship between menstrual disorders and low levels of vitamin D, which may be related to AMH, insulin, and androgen.
  54. [54]
    Benefits of physical activity on reproductive health functions among ...
    May 12, 2023 · Australian guidelines for the management of PCOS recommended at least 150 min of moderate-level exercise each week [10]. The time of the ...
  55. [55]
    Effects of mind-body interventions on polycystic ovary syndrome - NIH
    Jul 25, 2024 · This meta-analysis suggests that MBI represents a promising alternative therapy for patients with PCOS. MBI shows beneficial effects on the quality of life and ...
  56. [56]
    Effects of Yoga for Coping with Premenstrual Symptoms in Taiwan ...
    Apr 21, 2023 · In our research, we found that yoga exercises for three months could effectively alleviate premenstrual symptoms, including depressive symptoms ...Missing: irregular | Show results with:irregular
  57. [57]
    How Stress Affects Your Menstrual Cycle | UT Physicians
    May 16, 2025 · “Some studies have observed that over 70% of women experience recovery if their absent periods were associated with psychological stress or ...
  58. [58]
    Menstrual Cycle Tracking Applications and the Potential for ... - NIH
    Apps can be useful tools for tracking and accomplishing health goals [1, 2]. A segment of these health apps is used to track menstrual cycles.
  59. [59]
    Tracking of menstrual cycles and prediction of the fertile window via ...
    Aug 13, 2022 · Previous studies have used physiological parameters, such as basal body temperature (BBT) and heart rate (HR), to predict the fertile window and menses.Table 1 · Table 3 · Principal Findings
  60. [60]
    Use of Vitex agnus-castus in patients with menstrual cycle disorders
    Feb 23, 2024 · A significant number of patients reported improvement in menstrual pain (85.2%), bleeding intensity (83.4%) and frequency (79.2%) during the ...
  61. [61]
    Chasteberry - PubMed
    The current literature supports the use of chasteberry for cyclical breast discomfort and premenstrual syndrome; data on its use for menstrual irregularities ...
  62. [62]
    Oral Contraceptive Pills - StatPearls - NCBI Bookshelf - NIH
    3 types of oral contraceptive pills are broadly prescribed: combined estrogen-progesterone, progesterone-only, and continuous or extended-use pills.Continuing Education Activity · Indications · Administration · Adverse Effects
  63. [63]
    General Approaches to Medical Management of Menstrual ... - ACOG
    The purpose of this document is to review currently available management options, general principles, and counseling approaches for reproductive-aged patients ...
  64. [64]
    Progesterone Challenge A Diagnostic Test for Secondary Amenorrhea
    Sep 17, 2020 · The progesterone challenge test is done by giving oral medroxyprogesterone acetate (Provera) 10 mg daily for 5-10 days or one intramuscular injection.
  65. [65]
    a systematic review and meta-analysis of randomized controlled trials
    Available evidence has shown that metformin improves insulin sensitivity and weight management in polycystic ovary syndrome (PCOS).Introduction · Methods · Results · Discussion
  66. [66]
    Hypothyroidism and Its Impact on Menstrual Irregularities in ... - PMC
    Jun 25, 2024 · Thyroid hormone replacement therapy led to a decrease in menstrual blood loss. Elevated TPOAb (>55 IU/mL), Amenorrhea, 50, <0.05***, The ...
  67. [67]
    Does Hypothyroidism Affect Menstrual Periods? Things to Know
    Jul 16, 2024 · A medication called levothyroxine is the standard treatment for hypothyroidism. It can help improve menstrual cycle irregularities by boosting ...
  68. [68]
    GnRH agonists in the treatment of symptomatic endometriosis - PMC
    Pituitary GnRH receptor down-regulation leads to a hypogonadotropic and secondary hypoestrogenic state resulting in lesion regression and symptom improvement.Missing: menstrual | Show results with:menstrual
  69. [69]
    Management of Acute Abnormal Uterine Bleeding in Nonpregnant ...
    The pelvic examination also will determine the amount and intensity of bleeding and will identify any uterine enlargement or irregularity, which can be ...
  70. [70]
    Heavy menstrual bleeding: work-up and management - PMC
    Heavy menstrual bleeding (HMB), which is the preferred term for menorrhagia, affects ∼90% of women with an underlying bleeding disorder and ∼70% of women on ...
  71. [71]
    Endometrial ablation - Mayo Clinic
    The goal of endometrial ablation is to reduce how much you bleed during periods, also called menstrual flow. In some people, menstrual flow may stop completely.
  72. [72]
    Levonorgestrel-releasing intrauterine device to treat abnormal ... - NIH
    Dec 6, 2023 · Overall effectiveness of LNG-IUD in reducing menstrual bleeding was 82%. The proportion whose bleeding decreased was 95.50% in the endometrial ...
  73. [73]
    Levonorgestrel Intrauterine System versus Medical Therapy for ...
    Jan 10, 2013 · The levonorgestrel-IUS was more effective than usual medical treatment in reducing the effect of heavy menstrual bleeding on quality of life.
  74. [74]
    Anovulation - PMC - NIH
    Disorders of ovulation account for about 30% of infertility and often present with irregular periods (oligomenorrhoea) or an absence of periods (amenorrhoea).
  75. [75]
    Anovulation: Signs, Symptoms, Causes & Treatment - Cleveland Clinic
    : PCOS is a common condition that causes 70% of anovulation cases. PCOS ... In general, the diagnosis of anovulation is having irregular periods. Your ...
  76. [76]
    Polycystic Ovarian Syndrome - StatPearls - NCBI Bookshelf
    Jul 7, 2025 · Over their life span, we see that females with PCOS have a higher risk of developing infertility, high-risk pregnancy, miscarriage, diabetes, ...
  77. [77]
    Evidence-based guideline: Premature Ovarian Insufficiency (2025)
    The guideline group recommends the following diagnostic criteria: disordered menstrual cycles (spontaneous amenorrhea or irregular menstrual cycles) for at ...
  78. [78]
    Menstruation and Menstrual Disorders: Anovulation | GLOWM
    For nonpregnant women aged 16–40 anovulation is considered abnormal and a cause of infertility in 30% of fertility patients.<|separator|>
  79. [79]
    an independent risk factor for gestational diabetes mellitus - PubMed
    Conclusion: A history of irregular menstrual cycles was a significant independent predictor of gestational diabetes mellitus. If selective screening is ...Missing: hormonal imbalance
  80. [80]
    Fertility preservation for genetic diseases leading to premature ... - NIH
    Also, patients at risk of premature ovarian insufficiency (POI) could benefit from the preservation of fertility due to cryopreservation of reproductive ...
  81. [81]
    Insulin resistance, polycystic ovary syndrome, and type 2 diabetes ...
    The risk of type 2 diabetes mellitus among PCOS patients is 5- to 10-fold higher than normal. In turn, the risk of PCOS among reproductive-aged type 2 diabetes ...
  82. [82]
    Diabetes and Polycystic Ovary Syndrome (PCOS) - CDC
    May 15, 2024 · PCOS can cause irregular menstruation (periods), and is a common cause of infertility, affecting as many as 5 million women. In addition to ...
  83. [83]
    Complications and challenges associated with polycystic ovary ...
    Finally, a more recent systematic review and meta-analysis showed that women with PCOS appear to be at increased risk of nonfatal stroke and possibly coronary ...
  84. [84]
    Bone health in functional hypothalamic amenorrhea - PMC - NIH
    Oct 11, 2022 · In amenorrheic AN women, BMD declines by 2.4% at the hip and by 2.6% at the spine annually (8).
  85. [85]
    Hypothalamic Amenorrhea and the Long-Term Health Consequences
    Feb 13, 2019 · Reduced BMD due to low estrogen results in diffuse bone loss seen in the trabecular (spongy) bone underscoring the severity of FHA on the ...
  86. [86]
    Endometrial Cancer Prevention (PDQ®) - NCI
    Apr 10, 2025 · Based on solid evidence, unopposed estrogen is associated with an increased risk of endometrial cancer. This excess risk can be eliminated ...Missing: chronic anovulation
  87. [87]
    Risk of endometrial cancer in patients with polycystic ovarian ... - PMC
    Chronic anovulation encountered in PCOS is a key factor in exposing the endometrium to prolonged unopposed oestrogen (12,13).
  88. [88]
    Endometrial Cancer - ACOG
    You may first have a transvaginal ultrasound exam. This exam measures the thickness of the endometrium and the size of the uterus. A thicker endometrium means ...
  89. [89]
    Polycystic Ovary Syndrome (PCOS) - ACOG
    This condition increases the risk of endometrial cancer. Women with PCOS also may be at higher risk of sleep disorders, such as sleep apnea. The risk of ...
  90. [90]
    Depression and Its Effect on the Menstrual Cycle - PMC
    Jul 21, 2021 · Depression alters the hypothalamic-pituitary axis which leads to menstrual irregularities. Our results demonstrate that women with depressive ...
  91. [91]
    Anxiety and Depression in Women with Polycystic Ovary Syndrome
    Jul 16, 2022 · The women with PCOS had higher levels of anxiety and depression and poorer ego-resiliency in comparison to the healthy women.